Hypoalbuminaemia in haemodialysis patients at Parirenyatwa group of hospitals and Chitungwiza central hospital

Hypoalbuminaemia in haemodialysis patients at Parirenyatwa group of hospitals and Chitungwiza central hospital

 

Pasipanodya Ian Machingura^1,&, Needmore Muchadura Mahiya¹, Vasco Chikwasha²

 

¹University of Zimbabwe College of Health Sciences Department of Medical Laboratory Sciences, Zimbabwe, ²University of Zimbabwe College of Health, Sciences Department of Community Medicine, Zimbabwe

 

 

^&Corresponding author
Pasipanodya Ian Machingura, University of Zimbabwe College of Health, Sciences Department of Medical Laboratory Sciences, Zimbabwe

 

 

 

 

End stage renal disease is an important public health problem. Renal replacement therapy, dialysis and transplantation are used to provide relief from the symptoms of end stage renal disease whilst also preserving the life of the patients though they are not curative. Haemodialysis is the widely used method although it produces a negative impact on quality of life of the patients [1]. Hypoalbumianemia has been reported to be frequently present in haemodialysis patients and correlates strongly with mortality and morbidity. Levels of albumin are decreased in patients with inflammatory states, thus it's not clear to what extent hypoalbuminemia is due to malnutrition or simply a reflection of inflammatory states [2]. Patients with advanced chronic kidney disease who receive chronic hemodialysis treatment suffer from various degrees of protein energy wasting. Low serum albumin is one of the key diagnostic criteria proposed by the International Society of Renal Nutrition Experts Panel [3]. Serum albumin is still the most common nutritional marker used in end stage renal disease patients [4]. Serum albumin measurement is a simple and readily available test [5]. We sought out to determine the prevalence of hypoalbuminaemia among haemodialysis patients at Parirenyatwa group of hospitals and Chitungwiza central hospital.

 

 

Data and sample collection

 

Permission to carry out the project was sought from the authorities at Parirenyatwa Group of Hospitals, Chitungwiza Central Hospital and Joint Research Ethics Committee of the College of Health Sciences. Only patients who consented were recruited into the study between January and February 2013. A questionnaire was administered on haemodialysis patients at Parirenyatwa Group of Hospitals and Chitungwiza Central Hospital who consented to participate in the study. The questionnaire was used to collect demographic information and other information from the patient. Serum from the pre dialysis blood samples collected from the patients was used for albumin analysis.

 

Biochemical analysis

 

The serum from the patients was analysed for serum albumin levels using the Mindray BS120 chemistry analyser using the bromocresol green method. The analyser was calibrated and control samples were analysed before analysis of samples. Samples were only analysed when the control samples were within their reference range. The samples were processed and results were recorded for statistical analysis.

 

Data analysis

 

The data was captured using Microsoft excel and exported to Stata 12 for cleaning and analysis. Patients characteristics were summarized using mean (SD) for continuous normally distributed variables. Categorical variables were summarized using frequencies and percentages. Hypoalbuminaemia was defined as serum albumin less than 38g/l [3, 5, 6].

 

 

A total of 60 patients were enrolled into the study with a mean age of 46.7 years, SD (13.5 years). The majority of the patients 70% (42/60) were male. There was no significant difference in age distribution between males (mean age=48.5 years, SD=12.8 years) and females (mean age=42.7 years, SD=14.6 years), (p=0.134). Mean albumin concentration for the entire group was 33.6g/L SD (6.1 g/L). The mean albumin in males was 33.6 g/L, SD (5.9) and in female 33.6, SD (6.6 g/L) and this was not statistically significantly different (p=0.988). Prevalence of hypoalbuminaemia was 76.7% (Table 1). Being female had a protective effect against hypoalbuminaemia compared to being male but this was not statistically significant, OR=0.71, 95% CI (0.20-2.52), p=0.595. The odds of developing hypoalbuminaemia increased with age but was not statistically significant, OR=1.02, 95% CI (0.98-1.07), p=0.318. Period on dialysis was not a significant predictor of hypoalbuminaemia OR=0.99, 95% CI (0.98-1.01). Having BP was not a significant predictor of hypoalbuminaemia, OR=1.75, 95% CI (0.29-10.74), p=0.546.

 

 

It has been reported that morbidity and mortality incidence of dialysed patients with hypoalbuminemia is higher than in patients with normal serum albumin [7]. Mean albumin concentration for the entire group was 33.6g/L SD (6.1 g/L). The mean albumin in males was 33.6 g/L, SD (5.9) and in female 33.6, SD (6.6 g/L) and this was not statistically significantly different (p=0.988). This is a cause of concern since patients with a serum albumin levels below 35g/L have been reported to have a relative mortality risk of 4 or a 2 year survival of 20% when compared with a 2 year survival of 80% in those with serum albumin greater than 40g/L [8]. The mean albumin of the entire group was less than 40.7g/L reported in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospital during the year 2010 [4].

 

In dialysis patients low serum albumin level indicates more severe comorbidity, worse general health status and protein energy wasting [3]. The prevalence of hypoalbuminemia in this study was found to be 76.7% which is lower than that reported in Pakistan of 90.6% [9]. The study in Parkistan used a cut of for hypoalbuminaemia of 40g/L which is more than the 38g/L which is currently recommended. In dialysis patients the amino acid and protein losses during the dialysis session and the low nutrient intake leads to low nutrient availability for muscle synthesis [10]. Oral nutritional supplements and other nutritional interventions to chronic kidney disease patients have been suggested to increase serum albumin levels and improve longevity and their quality of life [5]. Several studies have reported that haemodialysis patients eat less protein and fewer calories than prescribed and are associated with higher rates of malnutrition [8].

 

 

Hypoalbuminaemia in 76.7% of haemodialysis patients studied is a cause of concern thus monitoring of haemodialysis patients albumin is necessary since its decreased levels has been associated with increased morbidity and mortality.

 

 

Authors declare no competing interest.

 

 

Pasipanodya Ian Machingura: Study design and manuscript preparation. Needmore Muchadura Mahiya: data and sample collection and laboratory analysis. Vasco Chikwasha: study design and statistical analysis. All authors read and approved the final version of the manuscript.

 

 

We would like to thank staff and patients at Parirenyatwa Group of Hospital Renal Clinic and Chitungwiza Central Hospital Renal clinic, Mrs Nehowa and Mr Nyakuedzwa for their cooperation.

 

 

Table 1: prevalence of hypoalbuminaemia

 

 

1. Cavalcante MCV, Lamy ZC, Filho FL, Franca AKT, Dos Santos AM, Thomaz EBAF, Da Silva AAM, Filho NS. Factors associated to salt intake in chronic hemodialysis patients. J Bras Nefrol. 2013 Apr-Jun; 35(2): 87-92. PubMed | Google Scholar


2. Leon JB, Albert JM, Gilchrist G, Kushner I, Lerner E, Mach S, Majerle A, Porter D, Ricanati E, Sperry L, Sullivan C, Zimmerer J, Sehgal A. Improving Albumin Levels Among Hemodialysis Patients: a community-based randomized controlled trial. American Journal of Kidney Disease. 2006; 48 (1): 28-36. PubMed | Google Scholar


3. Kim Y, Molnar MZ, Rattanasompattikul M, Hatamizadch P, Benner D, Kappler JP, Kavesdy CP, Kalantar, Zadch K. Relative contributions of inflammation and inadequate protein intake to hypoalbuminemia in patients on maintenance hemodialysis. Int Urol Nephrol. 2013; 45(1):215-227. PubMed | Google Scholar


4. Dashti N, Einollahi N, Nabatchian F, Moradi Sarabi M, Zarebajani M. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010. Acta Med Iran. 2012; 50(3):197-202. PubMed | Google Scholar


5. Jadeya VP and Khei V. Protein energy wasting in chronic kidney disease: an update with focus on nutritional interventions to improve outcomes. Indian Journal of Endocrinology and metabolism. 2012; 16(2):246-251. PubMed | Google Scholar


6. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guamieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkei P, Trevinho-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidneydisease. Kidney International. 2008; 73(4): 391-398. PubMed | Google Scholar


7. Galic G, Tomic M, Galesic K, Kvesic A, Soljic M, Mozetic V, Loncar Z, Maricic A, Martinovic Z. Hypoalbuminemia and complication incidence in haemodialyseduremic patients. Coll Antropol. 2009; 33(2): 559-566. PubMed | Google Scholar


8. Fouque D, Vennegoor M, Wee PT, Wanner C, Basci A, Canaud B, Haage P, Kanner K, Kooman J, Martin-Malo A, Pedrini L, Pizzarella F, Tattersall J, Tordoir J, Vanholder R. EBPG Guideline on Nutrition. Nephrol Dial Transplant. 2007; 22 (2): ii45-ii87. PubMed | Google Scholar


9. Siddiqui UA, Halim A, Hussain T. Nutritional profile and inflammatory status of stable chronic haemodialysis patients at nephrology department, Millitary Hospital Rawalipindi. J Ayub Med Coll Abbottabad. 2007;19(4): 29-31. PubMed | Google Scholar


10. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalanter-Zaden K, Kaysen G, Mitch WE, Price SR, Wanner C, Wang AYM, Wee P, Franch HA. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism. Journal of Renal Nutrition. 2013; 23 (2): 77-90. PubMed | Google Scholar